🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Associations between multidomain modifiable dementia risk factors with AD biomarkers and cognition in middle-aged and older adults

Neurobiology of Aging(2024)10.1016/j.neurobiolaging.2024.02.015Source: DataRank Database

Associations between multidomain modifiable dementia risk factors with AD biomarkers and cognition in middle-aged and older adults is a research paper published in Neurobiology of Aging (2024). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 1.63)OA: hybridTopics (54)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Nawaf Yassi ORCID,Emily Rosenich ORCID,Rachel F. Buckley ORCID,Qiao‐Xin Li ORCID,Paul Maruff ORCID

Live enrichment

PubMed:38537555 OpenAlex:https://openalex.org/W4392350161

Dementia Australia Research Foundation

Grant: 23AARF-1025519

National Health and Medical Research Council

Grant: GNT1111603

Genetic mechanisms that moderate effects of Aβ accumulation in preclinical Alzheimer's disease

National Health and Medical Research Council

Grant: GNT1158384

Effects of Poor Sleep on Alzheimer’s Disease Pathogenesis: Extending the Glymphatic Flow Hypothesis

National Health and Medical Research Council

Grant: GNT1105576

What can tau deposition tell us about the appearance of subjective and objective cognitive decline in older adults?

National Health and Medical Research Council

Grant: GNT1171816

National Health and Medical Research Council

Grant: GNT1162645

Biological, genetic and lifestyle moderators of Alzheimer's pathogenesis, cognitive decline and clinical disease progression

National Health and Medical Research Council

Grant: GNT2009550

National Health and Medical Research Council

Grant: GNT1147465

A multi-cohort investigation of the effects of BDNF Val66Met on tau, neurodegeneration and cognition in preclinical Alzheimer’s disease

National Health and Medical Research Council

Grant: GNT1104273

Vascular Cognitive Risk Score: quantifying the vascular burden in Alzheimer's Disease

National Institutes of Health

Grant: K99AG061238

National Institutes of Health

Grant: K99-R00

Alzheimer's Association

Grant: AARG-18-591358

Alzheimer's Association

Grant: AARG-17-591424

Alzheimer's Association

Grant: AARG-19-643133

National Heart Foundation of Australia

Grant: GNT102052

Dementia Australia

FWCI

1.63

Citation Percentile

0.8%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.neurobiolaging.2024.02.015

publisherhttps://doi.org/10.1016/j.neurobiolaging.2024.02.015

publisherhttps://api.elsevier.com/content/article/PII:S0197458024000496?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0197458024000496?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38537555

Fields of Study

Dementia and Cognitive Impairment ResearchNutritional Studies and DietAlzheimer's disease research and treatments03 medical and health sciences0302 clinical medicineHumansMiddle AgedAgedAlzheimer Diseasetau ProteinsCognitionAmyloid beta-PeptidesBiomarkersRisk FactorsCognitive Dysfunction

MeSH Terms

AgedAlzheimer DiseaseCognitionHumansMiddle AgedRisk FactorsBiomarkersAmyloid beta-Peptidestau ProteinsCognitive Dysfunction

Keywords

CognitionDementiaMoodBrain sizeNeuropsychologyPsychologyInternal medicineMedicineClinical psychologyGerontologyOncologyPsychiatryDiseaseMagnetic resonance imagingTauAlzheimer’s diseaseMultidomainModifiable Dementia Risk FactorsAmyloid beta-Peptides150tau ProteinsMiddle AgedAlzheimer DiseaseRisk Factors616HumansCognitive DysfunctionBiomarkersAged